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Sunday, February 16, 2014 185aNADH and FADH2, the electron donors for the respiratory chain. NO competes
with O2 to slow down electron transfer at the respiratory chain. NO is produced
by NO synthases (NOS), with nNOS and eNOS dominating in cardiomyocytes,
while the existence of a mitochondrial NOS (mtNOS) is controversial. Since
nNOS, eNOS and putative mtNOS are regulated by Ca2þ, we speculated that
endogenous NO controls respiration during beta-adrenergic stimulation.
Methods and Results: Experiments were performed on murine and guinea-pig
mitochondria or cardiomyocytes. In mitochondria, ADP accelerated O2 con-
sumption and oxidized NADH, while the NO-donor spermine-NONOate in-
hibited ADP-induced respiration and reduced NADH. Cardiomyocytes were
loaded with NO-sensitive DAF-DA, which locates to cytosol and mitochondria,
and paced at 0.5 Hz. Isoproterenol plus elevation of stimulation frequency to
5 Hz increased cellular DAF-DA fluorescence by ~12% within 3 minutes,
which was abrogated by inhibition or genetic ablation of nNOS, but not
eNOS. Dialyzing myocytes with DAF-free pipette solution eliminated >50%
of DAF fluorescence, with remaining DAF signals deriving from mitochondria.
After beta-adrenergic stimulation, a smaller increase in DAF fluorescence re-
mained, which was abrogated by nNOS KO, but not by Ru360 (1mM in pipette),
a blocker of the mitochondrial Ca2þ uniporter. The redox states of NADH and
FADH2 were dynamically regulated after isoproterenol/5Hz, but not different
after nNOS inhibition or KO.
Conclusions: During beta-adrenergic stimulation, most endogenous NO derives
from nNOS, but not eNOS, while mtNOS plays no role under these conditions.
Although NO inhibits mitochondrial respiration in isolated mitochondria, the
endogenous concentrations produced in myocytes during beta-adrenergic stim-
ulation do not affect respiration.
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Mitochondria play vital roles in energy metabolism, apoptosis, oxidative stress,
aging, and neurodegenerative disease [1]. In this contribution, we probe
different aspects of cellular response to chemical-induced oxidative stress in
living C3H10T1/2 cells using hydrogen peroxide, rotenone, and excess
glucose. Using two-photon fluorescence lifetime imaging microscopy
(2P-FLIM), we exploit the autofluorescence dynamics of natural coenzymes
such as nicotinamide adenine dinucleotide (NADH), flavin adenine dinucleo-
tide (FAD) and flavoproteins as intrinsic biomarkers for oxidative stress. The
effects of polarization selectivity in 2P-FLIM measurements are being in-
vestigated towards the development of a quantitative, genuine non-invasive
2P-FLIM of patho-physiological changes in living cells. The efficiency of
2P-FLIM cellular autofluorescence for monitoring changes in the metabolic
and redox states of the cells is compared with conventional assays such as
MitoSOX Red, JC-1, and Rhodamine-123 that are routinely used for oxidative
stress studies. Our results help in the collective effort to establish cellular auto-
fluorescence as a natural biomarker for biological and biomedical studies.
1.Heikal,A.A. Intracellular coenzymes as natural biomarkers formetabolic activ-
ities and mitochondrial anomalies. Biomarkers in Medicine, 4(2): 241-63 (2010).
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More than 120,000 individuals treated with lifesaving antibiotics develop hear-
ing or balance disorders annually. Although research has shown that of the two
cochlear cell types, sensory and supporting cells, sensory cells are readily
damaged due to age-related hearing loss, acoustic trauma and ototoxins, the
reason for this remains unknown. Furthermore, cochlear sensory hair cells
can be divided into two types, inner and outer hair cells (IHCs, OHCs).
OHCs in the high-frequency region of the cochlea exhibit the greatest sensi-
tivity to the above conditions. To determine if variations in sensory and sup-
porting mitochondrial metabolism account for these differences, two-photon
fluorescence lifetime microscopy (FLIM) was used to measure changes in
the metabolic reporter molecule NADH in sensory and supporting cells fromexplanted murine cochleae. Mitochondrial uncouplers, inhibitors and an
ototoxic antibiotic, gentamicin (GM), were used to assess high- and low-
frequency IHC, OHC and supporting cell mitochondrial metabolism. Chemi-
cally induced changes in metabolic state resulted in a reorganization of specific
NADH lifetimes into altered subcellular fluorescence lifetime pools. Variations
in NADH intensity and average NADH lifetime were greatest in high-
frequency OHCs. Pretreatment with GM significantly increased NADH inten-
sity in high-frequency sensory cells but not supporting cells. Treatment with
GM significantly increased the average NADH fluorescence lifetime within
IHCs but not OHCs. GM also caused a significant increase of NADH concen-
tration in OHCs, not IHCs. These results demonstrate: differences between sen-
sory and supporting cell metabolism; GM alters mitochondrial metabolism; and
IHCs and OHCs display differing metabolic effects when exposed to GM. Such
fundamental differences between sensory and supporting cell mitochondrial
metabolism indicate differing metabolic changes during antibiotic exposure.
Understanding these antibiotic-induced metabolic changes may explain the
ototoxic effects of these drugs which is crucial for preventing and treating
numerous auditory deficits and diseases.
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Aminoglycosides, including gentamicin (GM), are the most frequently used an-
tibiotics in the world despite irreversible cochlear damage and hearing loss asso-
ciated with their use. Although there are numerous causes of deafness, reactive
oxygen species (ROS) are key regulators of multiple pathologies including:
ototoxicity, noise-induced and age-related hearing loss. Unfortunately, the
source of these cell-damaging ROS remains controversial. Given that ROS are
normal byproducts of ATP synthesis, intrinsic differences in cochlear sensory
(inner and outer hair cell, I/OHC) and supporting (pillar) cell mitochondrial
metabolism may explain why high-frequency OHCs are profoundly sensitive
to a host of challenges. Mitochondrial metabolism was compared in low-
frequency and high-frequency IHCs,OHCs and pillar cells fromacutely cultured
cochlear explants. Intensity-based changes in the metabolic intermediate, nico-
tinamide adenine dinucleotide (NADH), were used to measure endogenous,
mitochondrial toxin and GM-induced differences in sensory and supporting
cell mitochondrial metabolism. Sensory cell mitochondrial metabolism was
significantly enhanced relative to supporting cells. Despite similar amounts of
mitochondria in IHCs and OHCs, endogenous levels of NADH were greatest
in high-frequency OHCs. Metabolic profiling of NADH metabolism revealed
basal turn, high-frequency OHCs to be metabolically responsive to a number
of changes in their microenvironment includingmetabolic toxins andGM,while
high-frequency IHCs, low-frequency I/OHCs and, pillar cells are substantially
less sensitive.DHR-123was used to detect sensory and supporting cell ROS pro-
duction during GM exposure. Within 30 minutes of GM application, ROS are
dramatically and specifically increased in high-frequency sensory cells. GM-
induced changes in mitochondrial metabolism and cell-damaging free radical
production were greatest in high-frequency OHCs. This metabolic predisposi-
tion biases basal turnOHC responses to a variety of cochlear insults, particularly
those involving energy metabolism and ROS production.
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The heart is the first functional organ in a vertebrate embryo. Mitochondria
appear to be important to heart development and closing the permeability tran-
sition pore (PTP) between embryonic day (E) 9.5 and E11.5 drives the matura-
tion of mitochondrial structure and regulates myocyte differentiation. These
data also suggested that closure of the PTP is associated with changes of indi-
vidual complexes (Cx) of the electron transport chain (ETC), and the objective
here was to further define these changes.
We assessed the activity of the Cx- 1, Cx-2 and Cx-3 of the ETC of C57BL/6N
(wildtype (WT)) and cyclophilin D knockout (CypD KO) mice during embry-
onic development from E9.5 to E13.5 with a Clark-type oxygen electrode and
enzymatic assays. Our results show that at E9.5 mitochondrial oxygen con-
sumption appears uncoupled and there is no difference between state 2, 3
and 4 respiration. In contrast, oxygen consumption in E9.5 CypD KO embryos
186a Sunday, February 16, 2014shows distinct state 2, 3 and 4 respiration, which can be mimicked in E9.5 WT
hearts by incubation with 200 nM CsA. By E11.5 mitochondrial oxygen con-
sumption in WT hearts is not significantly different when compared to E11.5
CypD KO mice or E13.5 hearts.
In addition, supercomplexes were not detectable in WT hearts of E9.5 and
E11.5 embryos by native electrophoresis or immunocapturing. This may
explain why NADH-cytochrome c reductase activity is not detectable in WT
embryos at E9.5 but in E11.5 or E13.5 WT mice. Furthermore, Cx-1 is in its
de-active form at E9.5 and becomes activated around E11.5.
Our data suggests that at E11.5 the PTP is closed and Cx-1, Cx- 2 and Cx-3 of
the ETC are present, but are not yet arranged in supercomplexes and a coordi-
nated electron transfer is still developing.
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Parkinson’s disease (PD) is one of the most prevalent neurodegenerative disor-
ders, characterized by loss of dopaminergic neuron function; leading to brady-
kinesia andmotor dysfunction. It is observed that various geneswhich have been
implicated in the familial and sporadic forms of the disease are involved in path-
ways which focalize at the mitochondria. This organelle is a central regulator of
cell death, and mitochondrial dysfunction is a common phenomenon associated
with multiple neurodegenerative diseases. Not surprisingly, a clinical screen
identified PD-associated mutations in mitochondrial Hsp70 (mtHsp70), which
is a critical protein involved in mitochondria biogenesis and maintenance of ho-
meostasis. In order to specifically understand the role of the mtHsp70 protein,
we have developed a Saccharomyces cerevisiaemodel for studying the disease
variants in isolation from other players of this multifactorial disease. We gener-
ated the analogousmutants R103W and P486S in yeast mtHsp70 which remark-
ably recapitulated the symptoms of mitochondrial dysfunction in affected
neurons including cell death, increased generation of ROS,mtDNA loss and res-
piratory incompetence. Spectral analysis of a fluorescent carbocyanine dye up-
take in isolated mitochondria indicated compromised membrane potential
gradients as a cause for dysfunction. At the molecular level, circular dichroism
based-thermal melt analyses confirmed the observed in vivo aggregation pro-
pensity of R103W, while P486S exhibited futile enhanced interaction with J-
protein co-chaperone partners thereby resulting in loss of chaperoning activity
by mtHsp70. Remarkably, these altered biochemical properties reflect identical
defects found by us in the human mtHsp70 variants, thereby confirming a direct
involvement of mtHsp70 in PD progression. Thus, by utilizing the significant
structural and functional homology between the yeast and human mtHsp70 pro-
teins, and an integrated in vivo and in vitro approach, we demonstrate the basic
underlying mechanisms of mtHsp70 association with PD.
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The amphipathic tail-anchoring peptide (ATAP) derived from the human anti-
apoptotic protein Bfl-1 is a potent inducer of apoptosis by targeting mitochon-
dria permeability transition. By linking ATAP to an internalizing RGD peptide
(iRGD), selective targeting for ATAP to tumor cells could be achieved. Target-
ing of ATAP-iRGD peptide to tumorigenic cells resulted in mitochondrion-
dependent cell death through release of cytochrome c. Confocal fluorescence
microscopy showed that Dylight488-labeled ATAP-iRGD could effectively
penetrate into cells and distribute along the mitochondria network. Flow cytom-
etry results showed that expression level of integrinaV or integrinaVb3 recep-
tors is higher in ATAP-iRGD sensitive (DU145, KYSE-150 and PC3) cells,
when compared with ATAP-iRGD insensitive (K562 human leukemia cell)
cell line. These results indicate that integrins act as a receptor to mediate uptake
of ATAP-iRGD into the cancer cells. Studies with xenograft model showed that
intravenous injection of ATAP-iRGD could suppress the growth of several hu-
man carcinoma cells implemented into the nude mice. Toxicological studies re-
vealed that repetitive intravenous delivery of ATAP-iRGD did not produce
significant toxicity in different organs of the SV129 mice. Our data suggestthat ATAP-iRGD is a promising agent with high efficacy and limited toxicity
for cancer therapy.
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Myosin II inhibitor Blebbistatin is frequently used for heart immobilization
during imaging experiments involving ischemia/reperfusion (I/R). Here we
investigated the extent to which Blebbistatin modulates critical events during
I/R, such as mitochondrial membrane potential depolarization (DJm), asystole,
and infarction. Langendorff-perfused rabbit hearts were subjected to 60-90 mi-
nutes of ischemia and 180 minutes of reperfusion in the absence (control) or in
the presence of Blebbistatin (5.7 mM). We monitored DJm depolarization
using spectral analysis of confocal images yielded by cationic fluorescent
dye TMRM. We detected the onset of sarcolemmal permeabilization (SP) in
individual myocytes as a massive uptake of anionic dye DiBac4(3) or cell-
impermeable nucleic acid dye YO-PRO1. Control hearts were briefly perfused
with 20 mM potassium at 35 minutes prior to ischemia, and at 30 and 120 mi-
nutes of reperfusion to achieve immobilization necessary for confocal imaging.
In control hearts, cessation of contraction permitted confocal imaging after
10-15 minutes of ischemia. Global and local bipolar electrograms monitored
electrical activity. During ischemia, Blebbistatin significantly (p<0.01) and
proportionally delayed both DJm depolarization (50.5 minutes versus
24.0 minutes in control) and asystole (40.2 minutes versus 22.3 minutes in con-
trol). Upon reperfusion, a heterogeneous DJm recovery was observed in both
groups, but Blebbistatin largely prevented SP events observed on a massive
scale in control hearts. Additionally, Blebbistatin almost completely prevented
infarction in this model (1.953.2% versus 75.057.8% in control by tetrazo-
lium chloride staining). Another electromechanical uncoupler, 2,3-Butane-
dione monoxime (20 mM), did not prevent SP and infarction despite efficient
immobilization. Conclusions: (1) great caution has to be exercised with regard
to interpretation of I/R events observed in the presence of Blebbistatin; (2) the
mechanism(s) of prominent cardioprotection by Blebbistatin may not be fully
explained by immobilization and deserve further study.
942-Pos Board B697
Role of Mitochondria-Cytoskeleton Interactions in Respiration Regulation
in Post-Infarct Heart Failure
Rafaela Bagur Quetglas.
TIMC-PRETA and LBFA, Joseph Fourier University, Grenoble cedex 9,
France.
The aim of this work is to study structural and functional organization of energy
metabolism in an ex vivo model of myocardial ischemia-reperfusion, focusing
on the role of mitochondria interactions with cytoskeletal proteins in the regu-
lation of mitochondrial respiration and dynamics. Hearts studied were sub-
jected to perfusion under normoxic, ischemia and ischemia-reperfusion
conditions using Langendorff system.
Hemodynamic measurements showed that reperfusion-dependent left ventricu-
lar diastolic dysfunction is related to increased affinity of respiration for ADP
(low app. Km for ADP). This loss of ADP microcompartmentalization was
associated with decreased functional coupling between oxidative phosphoryla-
tion and mitochondrial creatine kinase. Previous studies have shown that in
healthy adult cardiomyocytes, characterized by high apparent Km for ADP,
cytoskeletal protein b2 tubulin co-localises with mitochondria. Ischemia-
reperfusion injury induces the displacement of b2 tubulin from mitochondrial
position in cardiac muscle fibers with low apparent Km for ADP.
We conclude that ischemia-reperfusion effects on mitochondrial respiration
and dynamics could be related to the disruption of mitochondrial outer mem-
brane porin, VDAC, interaction with cytoskeletal proteins such as b2 tubulin.
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The critical events determining cell death in the aftermath of myocardial
ischemia/reperfusion (I/R) remain poorly understood. Here we investigated
